ASP Isotopes announced Thursday that its Quantum Leap Energy (QLE) subsidiary has entered “a non-binding Memorandum of Understanding (MOU) with a large publicly traded U.S. energy company that operates nuclear power stations”.

Under the agreement, the utility will evaluate options to provide support and potential financing for QLE’s planned U.S. facilities focused on High Assay Low Enriched Uranium (HALEU), LEU+, uranium conversion and deconversion services. Discussions could also lead to long-term enriched uranium supply contracts, according to the press release. QLE’s CEO described the move as an important validation of the need for reliable domestic fuel sources ahead of the 2028 Russian uranium import ban.

We’ve been tracking ASPI’s growth closely. We spotlighted them as “The Next Nuclear Story Stock” last year after their Silicon-28 supply deal and U.S. radiopharmacy acquisition. November brought news of the QLE private placement backed by investors linked to Donald Trump Jr. and Eric Trump. December even covered the regulatory green light for the Renergen acquisition in South Africa. We’ve also detailed the looming HALEU crunch and the 2028 ban in recent fuel-chain reports.

QLE’s Texas footprint keeps expanding. The company established their global headquarters in Austin, advanced its joint-venture plans with Fermi America (co-founded by former Energy Secretary Rick Perry) for a HALEU research and production site at the 11 GW HyperGrid campus near Pantex, and continues working with TerraPower and South Africa’s NESCA. With a former Constellation Energy executive on the board (Ralph Hunter) and Vistra already scaling its Texas nuclear fleet for AI power demand, it's worth speculating that this partnership is in coordination with CEG or VST. 

We also just covered TerraPower receiving the first NRC construction permit for a commercial-scale advanced reactor in nearly a decade. The company also signed a major agreement with Meta in January for up to eight Natrium units. These milestones directly relate to QLE’s position through their 2025 agreements, under which TerraPower is providing financing for QLE’s planned HALEU enrichment facility in South Africa and committing to long-term offtake.

Despite the growing list of partnerships, QLE has yet to enrich any uranium or break ground on any facilities for research or commercial development in the US. The pieces are falling into place for a domestic nuclear fuel renaissance, but the sector still needs actual production, not just paper commitments.